Head-to-head for women
Lttl vs MadeMed
Lttl and MadeMed both offer GLP-1 telehealth to women, but they make different trade-offs on PCOS and hormonal suitability, clinical oversight, price and access. Here they are side-by-side on the Luna Fit Score — our women's-health rubric.
Lttl
Ranked #21 for women · Grade B−
Luna Fit
Best for: Readers treating insulin resistance who want the month-to-month rate rather than a prepay rung, and who will open the plan selector: the real ladder is public, complete and honest, and it is one click from a headline figure that is not.
Visit LttlMadeMed
Higher scoreRanked #6 for women · Grade B
Luna Fit
Best for: Women who expect to titrate and want to know today what month six costs, and who want an oral route available without switching provider.
Visit MadeMedThe verdict for women
MadeMed edges out Lttl on the Luna Fit Score, 84 to 81 (B vs B−). Women who expect to titrate and want to know today what month six costs, and who want an oral route available without switching provider. The reasoning behind that number is in what we found reviewing MadeMed.
Lttl is still a genuine option — publishes more of its pricing than anything else in this ranking — all 70 rungs, in the open, each labeled with what it actually bills — and then prints the same wrong “from $129/mo” on all fourteen product cards, four of which it would overcharge. Weigh the six women's-health factors below against your own priorities; our Lttl write-up for women goes through each of them, and if neither of these two is the one, our ranked shortlist of Lttl alternatives widens the field.
Side-by-side on the six factors
Both providers scored on the same women's-health rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | Lttl | MadeMed |
|---|---|---|
| Luna Fit Score | 81/100 · B− | 84/100 · B |
| Overall rank | #21 | #6 |
| Semaglutide | $199/mo month-to-month (from $129/mo on a 12-month plan billed $1,548 up front) — the product card advertises the $129 rung | $239/mo quarterly (from $199/mo on 6 months) |
| Tirzepatide | $279/mo month-to-month (from $199/mo on a 12-month plan billed $2,388 up front) — the product card advertises $129, which no tirzepatide tier costs | $399/mo quarterly (from $369/mo on 6 months) |
| Coverage | All 50 states plus Washington D.C., with a stated caveat that some services may not be | 40 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | Yes |
Luna Fit
Lttl
Ranked #21 · Grade B−
What we like
- Publishes its entire price ladder — every product, every term, every rung — in the public page source, each one labeled with what it bills (“$199/mo every month” beside “$1,548 annually”), with no intake quiz standing between you and the number
- A genuine month-to-month rung exists and is purchasable for every product, with no contracts and no minimum term, so the prepay ladder is an optional discount rather than the only way in
- Both molecules across three routes — injection, orally disintegrating tablet, and lower-dose microdose lines sold as their own products with their own published ladders rather than quoted at the full-dose price
The caveats
- All fourteen product cards hardcode “from $129/mo”. For semaglutide that is the twelve-month rung billed $1,548 up front; for tirzepatide, the semaglutide ODT and the microdose ODT it is a price purchasable at no tier at all
- The month-to-month rates are roughly 40% above the advertised figure — $199 for semaglutide and $279 for tirzepatide against the $129 on every card
- Names no medical director and no prescribing clinician, offers and requires no labs or bloodwork, and carries no third-party certification such as LegitScript
Luna Fit
MadeMed
Ranked #6 · Grade B
What we like
- One price at every dose, published dose by dose — semaglutide $239/mo from 0.25mg to 2.4mg, tirzepatide $399/mo from 2.5mg to 15mg
- LegitScript verified, with board-certified physician review and US compounding pharmacies
- Oral semaglutide and oral tirzepatide are both offered alongside the injections
The caveats
- Compounded medication is not FDA-approved the way brand Ozempic, Wegovy, or Zepbound are
- 40 states rather than nationwide — check yours before you start
- Tirzepatide is among the pricier entries in this ranking at $399/mo quarterly
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. Pricing, states and verification reflect each provider's public disclosures at last review; the Luna Fit Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Neither Lttl nor MadeMed is only worth comparing with the other. Lttl is also written up against CoreAge Rx, 12 points apart on the Luna Fit Score — see Lttl against CoreAge Rx, factor by factor. MadeMed is also written up against CoreAge Rx, 9 points apart — see MadeMed vs CoreAge Rx for women.
- Lttl vs CoreAge Rx
- Lttl vs Enhance MD
- Lttl vs yourEra
- MadeMed vs Sesame Care
- MadeMed vs HealthRX
- MadeMed vs Trimi
Or browse the full comparison hub.